A B S T R A C T The androgen resistance syndromes are generally felt to be due to quantitative or qualitative abnormalities of the androgen receptor. Some patients with testicular feminization have no demonstrable fibroblast cytosol androgen binding, whereas others have androgen binding in cultured fibroblasts that is thermolabile or fails to be stabilized by sodium molybdate. I describe here familial incomplete testicular feminization associated with reduced nuclear androgen retention. Fibroblasts, cultured from pubic skin biopsies of two phenotypic female 46XY siblings, were assayed for whole cell and nuclear uptake of [3H] Although whole cell binding studies at 370C showed minimally diminished androgen binding in the patients' cells compared with binding at 220C, Griffin (1979 . J. Clin. Invest. 64: 1624-1631.) has demonstrated thermolability of the androgen receptors in fibroblasts also cultured from these patients. The observations with intact cells coupled with the diminished cytosol 8S peak of [3H]dihydrotestosterone on sucrose gradients indicate that these patients have cytosol androgen receptors that are qualitatively abnormal physicochemically, the physiologic consequence of which is failure of nuclear androgen localization. Thus, although the underlying defect in the pathogenesis of the androgen resistance in these patients appears to reside in the androgen receptor, the crucial biologic manifestation of the molecular lesion is impaired nuclear androgen retention. These experiments, therefore, suggest that assessment of nuclear [3H]dihydrotestosterone uptake is an effective indicator of the functional integrity of the androgen receptor system in patients with various forms of androgen insensitivity and provides additional insights to those obtained by thermolability or cytosol sucrose gradient studies.
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Although whole cell binding studies at 370C showed minimally diminished androgen binding in the patients' cells compared with binding at 220C, Griffin (1979 . J. Clin. Invest. 64: 1624-1631.) has demonstrated thermolability of the androgen receptors in fibroblasts also cultured from these patients. The observations with intact cells coupled with the diminished cytosol 8S peak of [3H]dihydrotestosterone on sucrose gradients indicate that these patients have cytosol androgen receptors that are qualitatively abnormal physicochemically, the physiologic consequence of which is failure of nuclear androgen localization. Thus, although the underlying defect in the pathogenesis of the androgen resistance in these patients appears to reside in the androgen receptor, the crucial biologic manifestation of the molecular lesion is impaired nuclear androgen retention. These experiments, therefore, suggest that assessment of nuclear [3H]dihydrotestosterone uptake is an effective indicator of the functional integrity of the androgen receptor system in patients with various forms of androgen insensitivity and provides additional insights to those obtained by thermolability or cytosol sucrose gradient studies.
INTRODUCTION
Male pseudohermaphroditism can occur either as a result of inadequate intrauterine androgen secretion or ineffective androgen action (1) . Among the conditions that occur as a consequence of insufficient androgen production there have been cases reported with deficiencies for each of the five enzymes involved in testosterone biosynthesis (2) . In a similar fashion, defects in androgen action could be expected to occur at any one of the links in the chain of steps involved in this complex intracellular process at the target tissues (3 Fibroblast strains were established in this laboratory from the patients and the normal male controls either from mons pubis punch biopsies (4-mm diam) or from genital skin specimens obtained at surgery. The specimens were finely minced in 60-mm petri dishes containing 4-5 ml of improved Eagle's minimal essential medium supplemented with 8% fetal calf serum; 10-7 M insulin; glutamine, 0.584 g/liter; collagenase, 2 mg/ml; penicillin, 100 U/ml; and streptomycin, 100 ,gg/ml; medium A. This medium was freshly prepared for each sample and filtered through a Swinnex-13 Millipore filter (Millipore Corp., Bedford, MA) immediately prior to use. After mincing the mixtures were transferred to 25-cm2 tissue culture flasks and maintained at 370C in the presence of 5% CO2 in a humidified incubator. After 24 h, the medium was changed to a growth medium (medium B) consisting of medium A without collagenase. When the cells became confluent (usually within 1-3 wk) they were detached from the flasks with 0.05% trypsin-0.02% EDTA in saline at 37°C and passed serially into 75-and 150-cm2 flasks. MCF-7 human breast cancer cells (provided by Dr. M. E. Lippman of the National Cancer Institute) were grown in a similar fashion. These cells have been shown to have androgen receptors with essentially the same binding properties as cultured human skin fibroblasts (15) and were used where indicated as controls.
Whole cell androgen binding assay. For routine assay, fibroblasts or MCF-7 cells were grown to confluence in four or five 150-cm2 tissue culture flasks. With fibroblasts this usually required 4-6 wk from the time of the initial seeding of the cell line. 2 d before assay the medium was changed to medium B, which lacks fetal calf serum (medium C). This was repeated again 24 h before the assay. The remainder of the procedure was as previously described (15) . The results were calculated with the aid of a computer (16) . Binding capacity was expressed as sites/cell. In some experiments, [3Hlmethyltrienolone was
Nuclear binding of [3H]DHT. The nuclear uptake of [3H]DHT was examined using a modification of the method of Tsai and Samuels (17) . Cells were prepared and incubated with [3H]DHT as in the whole cell assay except that binding was standardly performed at 37°C for 45 min. After incubation the cells were collected by centrifugation, resuspended in 2 ml of PBS, and recentrifuged. The cell pellets were suspended in ice-cold 2 ml buffer A (0.25 M sucrose, 1.1 mM MgCl2, 20 mM Tris, pH 7.85, and 0.5% Triton X-100) and then centrifuged at 1,000 g for 3 min to collect the nuclei. The crude nuclear pellet was resuspended in 2 ml of the same buffer and recentrifuged. Binding was assessed and calculated as for the whole cells, based on a cell count determined before the addition of buffer A.
Sucrose density gradient analysis. To prepare cytosol, cells that had been placed in medium C 24 h before were harvested with 0.01% Trypsin-0.02% EDTA in PBS, washed with PBS, suspended in buffer B (10 mM Tris-HCI, pH 7.4, 10 mM Na molybdate, 1.5 mM EDTA, 0.5 mM dithiothreitol), and homogenized with 40 strokes of a Dounce homogenizer (Kontes Co., Vineland, NJ). Cytosol was obtained by centrifugation of the homogenate at 100,000 g for 1 h at 40C, and incubated with 5 nM [3H]DHT for 3 h at 40C. Nonspecific binding was assessed by the addition of 10-6 M R1881. Pellets of dextran-coated charcoal (DCC) were obtained by centrifugation of 0.5 ml of DCC suspension (0.25 g/100 ml Norit A, 0.0025 g/100 ml dextran in 0.01 M Tris-HCI, pH 7.4) at 1,OOOg for 10 min; then 0.5 ml of the incubation mixtures were added, vortexed, and allowed to stand 10 min at 40C to remove unbound [3H]DHT. Following centrifugation for 10 min at 1,000 g at 4°C, 0.35 ml of the supernatant were collected from the bottom of the gradient and the radioactivity determined after the addition of 0.5 ml H20 and 5 ml Aquasol. ['4C]BSA was added to each gradient as an internal marker. Protein was measured by the method of Lowry et al. (18) . Table II , which provides data on the variability of the androgen binding by the MCF-7 cells, the precision of the assay is such that it is difficult to make any statement about quantitative changes in binding at one temperature vs. the other due to the interassay variability.
Sucrose gradient analysis of cellular extracts. When cytosol was prepared from one of the patient's fibroblasts in a sodium molybdate-containing buffer, incubated with [3H]DHT at 4°C and subjected to centrifugation on a sucrose gradient, a peak of radioactivity is demonstrable in the 8S region that is abolished in the presence of excess unlabeled methyltrienolone (Fig. 4) . However, when compared with cytosol from a normal fibroblast strain (normalized for protein content), this peak was quantitatively markedly reduced, -25% the area of the normal control.
As a means of verifying the results of the nuclear uptake studies with dispersed, intact cells, sucrose gradient analysis was also performed on 0.3 M KCI extracts of nuclei prepared from dispersed cells that had been incubated with [3H]DHT at 370C (Fig. 5) . In contrast to an easily identifiable peak of radioactivity in the 4S region of the gradient for the nuclear extract of the normal cells that was eliminated by coincubation 20 (20, 21) it is unlikely that using a higher salt containing solution to extract the nuclei would have significantly altered the results of the gradient analysis, since the amount of specific total radioactivity incorporated into the nuclei of the patients' cells is so low (Fig. 1 and Table I ).
DISCUSSION
The biologic action of the steroid hormones (and the calciferols) is generally agreed to be initiated at the target tissues by intracellular receptor proteins in the cytosol, which bind the active form of the hormone, are "activated" to a form that can enter the nucleus, and then transport the ligand to the nucleus (22 Although there is an abundance of biochemical data to support this overall scheme for all the steroids and 1,25-dihydroxycholecalciferol, studies from genetic errors or tissue culture-induced mutations have been few and thus far have supported the validity of this model for the mechanism of action for the glucocorticoids (23) (24) (25) , androgens (13) , and more recently with estrogens (26) and calciferols (27, 28) . The data presented in this paper demonstrate, that fibroblasts cultured from two siblings with male pseudohermaphroditism are unable to accumulate [3H]DHT within their nuclei despite the presence of intracellular androgen receptors. The characteristics of the nuclear uptake assay used in this study, which shows -40-50% of the binding sites found in the intact, whole cell, are in accord with published data (11, 19) . Also, the whole cell assay gives androgen binding characteristics for fibroblasts (15) and the MCF-7 cells that are also in good agreement with the results of others (21) . Moreover, the results of the sucrose gradient analysis on nuclear extracts shown in Fig. 5 clearly corroborate the validity of the results of the nuclear uptake assay with intact, dispersed cells.
Prior to this report, studies with cultured fibroblasts have revealed androgen resistance variants that are receptor-negative, receptor-deficient, and receptordefective (receptors that are thermolabile or are not stabilized by sodium molybdate) as well as receptor positive (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (24) (25) (26) (27) (28) (29) (30) (31) . Others have examined nuclear [3H]DHT uptake in fibroblasts from several patients with androgen resistance whose fibroblast whole cell
[3H]DHT uptake was apparently normal (10, 11, 20, 30) . In no case was the nuclear uptake of [3H]DHT absent. Such patients, on the basis of whole cell and nuclear [3H]DHT binding studies, would, therefore, be classified as having postreceptor resistance (PRR). Interestingly, Brown and his colleagues (32) have recently shown that one family, earlier found to have receptor-positive androgen resistance (10) , have qualitatively abnormal androgen receptors as judged by thermolability and rapid hormone dissociation (32) . These receptors were capable of conversion to a 3-4S form by exposure to high salt, indicating that a qualitative receptor abnormality does not necessarily preclude "activation" and nuclear binding. While the current studies were in progress, Medina et al. (33) have demonstrated decreased, but not absent, nuclear uptake of [3H]DHT in fibroblasts from a single patient with incomplete testicular feminization also presumably due to a receptor defect. From mixing experiments with cytosol and nuclear extracts from normal fibroblasts these workers concluded that the defect was due to diminished cytosol DHT serum-free medium for 48 h, dispersed with trypsin, washed, and resuspended in medium. Cells were incubated in test tubes in 1 ml of medium with increasing concentrations of the ligand indicated for 60 min to determine whole cell uptake or for 45 min to determine nuclear uptake at the temperature indicated. Nonspecific binding was determined in the presence of 10' M R1881. After incubation the cells were collected by centrifugation, washed with PBS, resuspended and exposed to ethanol before scintillation counting. Nuclear uptake was determined following the incubation by further exposing the washed cells to an isotonic buffer containing 0.5% Triton-X, centrifugation to collect the crude nuclear pellets, resuspension in PBS, and ethanol extraction. The binding parameters were calculated by Scatchard analysis. The data are normalized to cell number determined in a hemocytometer.
minished DHT-receptor complex nuclear localization. They did not distinguish between a quantitative or qualitative defect in the cytosol as the cause for the diminished DHT-receptor binding. Mean±SD.
Whole cell and nuclear uptake of [H]DHT in MCF-7 breast cancer cells were determined at the temperatures indicated as described in Table I. The inclusion of certain patients with androgen insensitivity in the PRR category on the basis of fibroblast studies was until recently presumptive and by exclusion because at the time these observations were made there was no technique other than hormone binding with which to examine these patients' cells. Specifically, in patients with PRR, the demonstration of absence of an androgen-induced biological response until a short time ago had been lacking since androgendependent effects in cultured fibroblasts had not been reported. Fortunately, Ozasa et al. (34) have shown that DHT, albeit at high doses, induces synthesis of protein and collagen but not DNA in normal fibroblasts. This effect was not present in fibroblasts from a patient with CTF in which there were only 10% the normal number of androgen receptors. Moreover, Kaufman et al. (35) have recently reported that fibroblasts from patients with PRR fail to "up-regulate" their androgen receptors following exposure to androgens as do normally responsive cells. These observa- The results of the studies reported here indicate that familial disorders of androgen action, like some mutant cell lines with disorders of glucocorticoid action, appear to have defective nuclear transfer as a means of hormone insensitivity (23) (24) (25) . The question remains, however, whether the inability of nuclear hormone uptake in these patients' fibroblasts is due to: (a) a qualitative abnormality in the cytosol receptor that has diminished affinity for chromatin or; (b) a defect in receptor activation analogous to the form of glucocorticoid resistance described by Schmidt et al. (25) . A defect in the nuclear "acceptors" appears unlikely.
Another question remains as to why there is some evidence of androgen sensitivity in the patients; to wit, the presence of epididymes and vas deferentia and the partially suppressed breast development. One is forced to conclude either that the defective nuclear androgen uptake is specific for only certain tissues such as the skin and the external genitalia or is incomplete throughout the body with certain target tissues being more affected than others. In this regard, it is interesting to note that microscopic epididymides have been described in the Tfm mouse (36) . The current techniques used here are relatively crude and would not preclude a small percentage of hormone-receptor complexes from binding to specific sites on the gene and triggering a partial virilizing response. In support of such a possibility Wieland and Fox have shown more than one kind of androgen receptor in Tfm mice using DNA-cellulose chromatography and isoelectric focusing (37, 38) . In light of the unusual phenotype of these two patients (i.e., virilization of the Wolffian structures but no clitoromegaly or labioscrotal fusion), it is possible that these features constitute a unique phenotype associated with impaired nuclear androgen retention. Application of the methodology used in this study to evaluate fibroblasts from other androgen-resistant patients who have thermolabile receptors or those that fail molybdate stabilization will help resolve this issue.
It is worth noting again that fibroblasts from these same patients have been analyzed previously (8, 9) 8 . Griffin has found that the androgen binding in these cells is labile at 420C, but less so at 370C, where the binding is diminished but detectable. Moreover, when the temperature was further lowered to 260C, the whole cell binding appeared to be within the normal range as is reported here. Griffin and Durrant have further reported that fibroblasts from some patients with thermolabile receptors, including those reported here, also have cytosol androgen receptors that cannot be stabilized by sodium molybdate to form an 8S binding species on sucrose density gradient centrifugation (9) . Although quantitatively much reduced compared with the normal control included in the same experiment (25%), Fig. 4 shows the presence of an 8S peak in the cytosol of the younger sibling's fibroblasts. Sucrose gradient analysis of cytosol from fibroblasts of the patient described by Medina et al. also showed a reduction in cytosol [3H]DHT binding (i.e., 35-40%) vs. normal. The thermolability of the androgen receptor in the intact cell incubations at 420C may be indicative of a receptor protein with altered stability so that after 3-h incubation and prolonged centrifugation at 00C, the 8S binding species is markedly reduced and difficult to detect. Whether or not sucrose gradient analysis of cytosol from such patients' cells is helpful, failure of nuclear androgen uptake may be more physiologically pertinent and may explain the defective androgen action in these patients.
These data provide an example for the androgen resistance syndromes of defective nuclear hormone uptake analogous to several insensitivity states already described for glucocorticoids and calciferols (23-25, 27, 28) . Currently, it is not clear whether the patient described by Medina et al. and the patients reported on here share the same molecular defect in androgen sensitivity. Although more rigorous studies will be required to ascertain the nature of the abnormality in the androgen receptor of patients with androgen insensitivity due to decreased nuclear androgen retention, assessment of fibroblast nuclear [3H]DHT uptake may complement information obtained from studies of thermolability or sodium molybdate stabilization in identifying the nature of the androgen resistance and in assessing the functional integrity of the androgen receptor system.
